{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:52:01Z","timestamp":1788205921927,"version":"build-2803163510"},"reference-count":136,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignancies heterogeneity represents a critical issue in cancer care, as it often causes therapy resistance and tumor relapse. Organoids are three-dimensional (3D) miniaturized representations of selected tissues within a dish. Lately, organoid technology has been applied to oncology with growing success and Patients Derived Tumor Organoids (PDTOs) constitute a novel available tool which fastens cancer research. PDTOs are in vitro models of cancer, and importantly, they can be used as a platform to validate the efficacy of anti-cancer drugs. For that reason, they are currently utilized in clinics as emerging in vitro screening technology to tailor the therapy around the patient, with the final goal of beating cancer resistance and recurrence. In this sense, PDTOs biobanking is widely used and PDTO-libraries are helping the discovery of novel anticancer molecules. Moreover, they represent a good model to screen and validate compounds employed for other pathologies as off-label drugs potentially repurposed for the treatment of tumors. This will open up novel avenues of care thus ameliorating the life expectancy of cancer patients. This review discusses the present advancements in organoids research applied to oncology, with special attention to PDTOs and their translational potential, especially for anti-cancer drug testing, including off-label molecules.<\/jats:p>","DOI":"10.3390\/cancers12123636","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T11:59:00Z","timestamp":1607083140000},"page":"3636","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9363-6523","authenticated-orcid":false,"given":"Silvia","family":"Vivarelli","sequence":"first","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Candido","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"},{"name":"Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7349-6826","authenticated-orcid":false,"given":"Luca","family":"Falzone","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, IRCCS Istituto Nazionale Tumori \u201cFondazione G. Pascale\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-7737","authenticated-orcid":false,"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy"},{"name":"Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1158\/0008-5472.CAN-15-3024","article-title":"Tumor Heterogeneity\u2014A \u2019Contemporary Concept Founded on Historical Insights and Predictions","volume":"76","author":"Welch","year":"2016","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jtbi.2014.02.025","article-title":"Evolution of acquired resistance to anti-cancer therapy","volume":"355","author":"Foo","year":"2014","journal-title":"J. Theor. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/s41467-020-18730-z","article-title":"Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence","volume":"11","author":"Walens","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ame2.12077","article-title":"The promises and challenges of patient-derived tumor organoids in drug development and precision oncology","volume":"2","author":"Granat","year":"2019","journal-title":"Anim. Model. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"188350","DOI":"10.1016\/j.bbcan.2020.188350","article-title":"Application of organoids in translational research of human diseases with a particular focus on gastrointestinal cancers","volume":"1873","author":"Nguyen","year":"2020","journal-title":"Biochim. Biophys. Acta-Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4196\/kjpp.2020.24.6.441","article-title":"Trends in the development of human stem cell-based non-animal drug testing models","volume":"24","author":"Lee","year":"2020","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Marshall, L.J., Triunfol, M., and Seidle, T. (2020). Patient-Derived Xenograft vs. Organoids: A Preliminary Analysis of Cancer Research Output, Funding and Human Health Impact in 2014\u20132019. Animals, 10.","DOI":"10.3390\/ani10101923"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13045-019-0832-4","article-title":"Emerging organoid models: Leaping forward in cancer research","volume":"12","author":"Fan","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13045-018-0662-9","article-title":"Organoid technology and applications in cancer research","volume":"11","author":"Xu","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stem.2015.05.004","article-title":"Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency","volume":"16","author":"Studer","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41580-020-0259-3","article-title":"Human organoids: Model systems for human biology and medicine","volume":"21","author":"Kim","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Fujii, M., and Sato, T. (2020). Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases. Nat. Mater.","DOI":"10.1038\/s41563-020-0754-0"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1242\/dev.140731","article-title":"Pluripotent stem cell-derived organoids: Using principles of developmental biology to grow human tissues in a dish","volume":"144","author":"McCauley","year":"2017","journal-title":"Development"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00109-017-1531-7","article-title":"Stem cell-derived organoids and their application for medical research and patient treatment","volume":"95","author":"Bartfeld","year":"2017","journal-title":"J. Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1083\/jcb.201610056","article-title":"Organoids: A historical perspective of thinking in three dimensions","volume":"216","author":"Simian","year":"2017","journal-title":"J. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1101\/gad.1061803","article-title":"In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells","volume":"17","author":"Dontu","year":"2003","journal-title":"Genes Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature07935","article-title":"Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche","volume":"459","author":"Sato","year":"2009","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/stem.2852","article-title":"Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models","volume":"36","author":"Kaushik","year":"2018","journal-title":"Stem Cells"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2217\/pme-2018-0071","article-title":"Importance of organoids for personalized medicine","volume":"15","author":"Perkhofer","year":"2018","journal-title":"Per. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"344ra84","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_24","first-page":"e55159","article-title":"Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients","volume":"120","author":"Boj","year":"2017","journal-title":"J. Vis. Exp."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kondo, J., and Inoue, M. (2019). Application of Cancer Organoid Model for Drug Screening and Personalized Therapy. Cells, 8.","DOI":"10.3390\/cells8050470"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1091\/mbc.E19-03-0135","article-title":"Human organoids: A new dimension in cell biology","volume":"30","author":"Lehmann","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1039\/C6IB00039H","article-title":"Three-dimensional models for studying development and disease: Moving on from organisms to organs-on-a-chip and organoids","volume":"8","author":"Jackson","year":"2016","journal-title":"Integr. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.devcel.2016.08.014","article-title":"Organoids: Modeling Development and the Stem Cell Niche in a Dish","volume":"38","author":"Kretzschmar","year":"2016","journal-title":"Dev. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mizutani, T., and Clevers, H. (2020). Primary Intestinal Epithelial Organoid Culture, Humana.","DOI":"10.1007\/978-1-0716-0747-3_11"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/0008-5472.CAN-19-2115","article-title":"An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin","volume":"80","author":"Wu","year":"2020","journal-title":"Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR\u2013Cas9 precision genome editing","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.semcancer.2018.06.005","article-title":"Patient-derived tumor organoids for prediction of cancer treatment response","volume":"53","author":"Nagle","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1038\/s41596-020-0379-4","article-title":"Establishment of patient-derived cancer organoids for drug-screening applications","volume":"15","author":"Driehuis","year":"2020","journal-title":"Nat. Protoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nature14415","article-title":"Sequential cancer mutations in cultured human intestinal stem cells","volume":"521","author":"Drost","year":"2015","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nm.3802","article-title":"Modeling colorectal cancer using CRISPR-Cas9\u2013mediated engineering of human intestinal organoids","volume":"21","author":"Matano","year":"2015","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/febs.14998","article-title":"Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids","volume":"287","author":"Buira","year":"2020","journal-title":"FEBS J."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Costales-Carrera, A., Fern\u00e1ndez-Barral, A., Bustamante-Madrid, P., Dom\u00ednguez, O., Guerra-Pastri\u00e1n, L., Cantero, R., del Peso, L., Burgos, A., Barb\u00e1chano, A., and Mu\u00f1oz, A. (2020). Comparative Study of Organoids from Patient-Derived Normal and Tumor Colon and Rectal Tissue. Cancers, 12.","DOI":"10.3390\/cancers12082302"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Shinozawa, T., Kimura, M., Cai, Y., Saiki, N., Yoneyama, Y., Ouchi, R., Koike, H., Maezawa, M., Zhang, R.-R., and Dunn, A. (2020). High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell\u2013Derived Organoids. Gastroenterology.","DOI":"10.1053\/j.gastro.2020.10.002"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eaay2574","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/1078-0432.CCR-19-3637","article-title":"Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity","volume":"26","author":"Bruun","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/gastro\/goy040","article-title":"Patient-derived organoids: A promising model for personalized cancer treatment","volume":"6","author":"Yang","year":"2018","journal-title":"Gastroenterol. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","article-title":"Self-Organized Formation of Polarized Cortical Tissues from ESCs and Its Active Manipulation by Extrinsic Signals","volume":"3","author":"Eiraku","year":"2008","journal-title":"Cell Stem Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature09941","article-title":"Self-organizing optic-cup morphogenesis in three-dimensional culture","volume":"472","author":"Eiraku","year":"2011","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett\u2019s Epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/nm.2470","article-title":"Isolation and in vitro expansion of human colonic stem cells","volume":"17","author":"Jung","year":"2011","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature12517","article-title":"Cerebral organoids model human brain development and microcephaly","volume":"501","author":"Lancaster","year":"2013","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","article-title":"Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure","volume":"165","author":"Qian","year":"2016","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.15252\/embj.201694700","article-title":"Self-organized developmental patterning and differentiation in cerebral organoids","volume":"36","author":"Renner","year":"2017","journal-title":"EMBO J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41593-019-0350-2","article-title":"Cerebral organoids at the air\u2013liquid interface generate diverse nerve tracts with functional output","volume":"22","author":"Giandomenico","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","article-title":"Individual brain organoids reproducibly form cell diversity of the human cerebral cortex","volume":"570","author":"Velasco","year":"2019","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/ncb3047","article-title":"Single luminal epithelial progenitors can generate prostate organoids in culture","volume":"16","author":"Chua","year":"2014","journal-title":"Nat. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cell.2014.12.021","article-title":"Organoid Models of Human and Mouse Ductal Pancreatic Cancer","volume":"160","author":"Boj","year":"2015","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1038\/ncomms9989","article-title":"The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids","volume":"6","author":"Kessler","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.gastro.2014.09.042","article-title":"In Vitro Expansion of Human Gastric Epithelial Stem Cells and Their Responses to Bacterial Infection","volume":"148","author":"Bartfeld","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/0008-5472.CAN-15-2402","article-title":"A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo","volume":"76","author":"Hubert","year":"2016","journal-title":"Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ncb3516","article-title":"Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium","volume":"19","author":"Turco","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/nm.4438","article-title":"Human primary liver cancer\u2013derived organoid cultures for disease modeling and drug screening","volume":"23","author":"Broutier","year":"2017","journal-title":"Nat. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41587-019-0048-8","article-title":"Tubuloids derived from human adult kidney and urine for personalized disease modeling","volume":"37","author":"Schutgens","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e100300","DOI":"10.15252\/embj.2018100300","article-title":"Long-term expanding human airway organoids for disease modeling","volume":"38","author":"Sachs","year":"2019","journal-title":"EMBO J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1038\/s41596-019-0160-8","article-title":"High-resolution 3D imaging of fixed and cleared organoids","volume":"14","author":"Dekkers","year":"2019","journal-title":"Nat. Protoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1158\/0008-5472.CAN-14-0663","article-title":"Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast Cancer","volume":"74","author":"Walsh","year":"2014","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature14966","article-title":"Single-cell messenger RNA sequencing reveals rare intestinal cell types","volume":"525","author":"Lyubimova","year":"2015","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/embr.201642613","article-title":"Organoid biobanking: Identifying the ethics","volume":"17","author":"Boers","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1002\/cpcb.66","article-title":"Initiation, Expansion, and Cryopreservation of Human Primary Tissue-Derived Normal and Diseased Organoids in Embedded Three-Dimensional Culture","volume":"82","author":"Clinton","year":"2019","journal-title":"Curr. Protoc. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.stem.2015.12.005","article-title":"Engineering Stem Cell Organoids","volume":"18","author":"Yin","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The hope and the hype of organoid research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1293\/tox.2020-0007","article-title":"Patient-derived xenograft (PDX) models: Characteristics and points to consider for the process of establishment","volume":"33","author":"Fujii","year":"2020","journal-title":"J. Toxicol. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bpg.2017.03.003","article-title":"From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix","volume":"31","author":"Willemse","year":"2017","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","article-title":"High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays","volume":"4","author":"Brandenberg","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fbioe.2019.00039","article-title":"Engineering Organoid Vascularization","volume":"7","author":"Grebenyuk","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41586-020-2724-8","article-title":"Homeostatic mini-intestines through scaffold-guided organoid morphogenesis","volume":"585","author":"Nikolaev","year":"2020","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Lawlor, K.T., Vanslambrouck, J.M., Higgins, J.W., Chambon, A., Bishard, K., Arndt, D., Er, P.X., Wilson, S.B., Howden, S.E., and Tan, K.S. (2020). Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation. Nat. Mater.","DOI":"10.1038\/s41563-020-00853-9"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/nm.3973","article-title":"Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell\u2013 and patient-derived tumor organoids","volume":"21","author":"Huang","year":"2015","journal-title":"Nat. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-018-0024-3","article-title":"Intra-tumour diversification in colorectal cancer at the single-cell level","volume":"556","author":"Roerink","year":"2018","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","article-title":"Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation","volume":"25","author":"Pasch","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","article-title":"Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing","volume":"10","author":"Nanki","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-020-2080-8","article-title":"Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli","volume":"580","author":"Puschhof","year":"2020","journal-title":"Nature"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jcmgh.2018.04.008","article-title":"A Method for Cryogenic Preservation of Human Biopsy Specimens and Subsequent Organoid Culture","volume":"6","author":"Tsai","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e101654","DOI":"10.15252\/embj.2019101654","article-title":"Xenograft and organoid model systems in cancer research","volume":"38","author":"Bleijs","year":"2019","journal-title":"EMBO J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid Cultures Derived from Patients with Advanced Prostate Cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients","volume":"161","author":"Francies","year":"2015","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"13308","DOI":"10.1073\/pnas.1516689112","article-title":"Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases","volume":"112","author":"Weeber","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.stem.2017.12.009","article-title":"Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression","volume":"22","author":"Seino","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","article-title":"A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity","volume":"172","author":"Sachs","year":"2018","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","article-title":"Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer","volume":"173","author":"Lee","year":"2018","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-18-0409","article-title":"A PDX\/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening","volume":"24","author":"Beshiri","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","article-title":"Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy","volume":"9","author":"Driehuis","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1073\/pnas.1803595116","article-title":"Mouse and human urothelial cancer organoids: A tool for bladder cancer research","volume":"116","author":"Mullenders","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","article-title":"An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity","volume":"11","author":"Calandrini","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1053\/j.gastro.2017.10.043","article-title":"MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma","volume":"154","author":"Lampis","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","article-title":"Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy","volume":"26","author":"Narasimhan","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_101","unstructured":"World Health Organization WHO (2020, November 05). WHO Tral Search. Available online: https:\/\/apps.who.int\/trialsearch\/Default.aspx."},{"key":"ref_102","unstructured":"NIH National Institutes of Health (2020, November 05). Clinical Trials NIH, Available online: https:\/\/clinicaltrials.gov\/."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijh.ijh_24_19","article-title":"The hallmarks of cancer and their therapeutic targeting in current use and clinical trials","volume":"9","author":"Getta","year":"2020","journal-title":"Iraqi J. Hematol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"100713","DOI":"10.1016\/j.drup.2020.100713","article-title":"Repurposing old drugs to fight multidrug resistant cancers","volume":"52","author":"Efferth","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41392-020-00213-8","article-title":"Overcoming cancer therapeutic bottleneck by drug repurposing","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: Identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Lin, Z., Li, G., Xu, X., and Mei, J. (2020). Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer?. Interact. Cardiovasc. Thorac. Surg.","DOI":"10.1093\/icvts\/ivaa213"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.21037\/atm-20-5627","article-title":"Aspirin and risk of different cancers: An umbrella meta-analysis","volume":"8","author":"Jiang","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3389\/fonc.2020.556243","article-title":"Association Between Statin Use and Prognosis of Breast Cancer: A Meta-Analysis of Cohort Studies","volume":"10","author":"Lv","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Caciolla, J., Bisi, A., Belluti, F., Rampa, A., and Gobbi, S. (2020). Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target. Molecules, 25.","DOI":"10.3390\/molecules25225351"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Chang, C.-H., Lee, C.-H., Ko, J.-C., Chang, L.-Y., Lee, M.-C., Zhang, J.-F., Wang, J.-Y., Shih, J.-Y., and Yu, C.-J. (2020). Effect of \u03b2-Blocker in Treatment-Na\u00efve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.583529"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e29911","DOI":"10.4161\/mco.29911","article-title":"Chloroquine and hydroxychloroquine for cancer therapy","volume":"1","author":"Manic","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Gagelmann, N., and Kr\u00f6ger, N. (2020). The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: A systematic review. Ann. Hematol.","DOI":"10.1007\/s00277-020-04316-8"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/S0140-6736(20)31240-X","article-title":"Cancer and COVID-19: What do we really know?","volume":"395","author":"Poortmans","year":"2020","journal-title":"Lancet"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e667","DOI":"10.1016\/S2589-7500(20)30192-8","article-title":"Artificial intelligence in COVID-19 drug repurposing","volume":"2","author":"Zhou","year":"2020","journal-title":"Lancet Digit. Heal."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/ijbs.24612","article-title":"Review of Drug Repositioning Approaches and Resources","volume":"14","author":"Xue","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ddtec.2017.04.001","article-title":"In vivo phenotypic screening: Clinical proof of concept for a drug repositioning approach","volume":"23","author":"Ciallella","year":"2017","journal-title":"Drug Discov. Today Technol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1087057114563024","article-title":"In Vitro Screening for Drug Repositioning","volume":"20","author":"Wilkinson","year":"2015","journal-title":"J. Biomol. Screen."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.biopha.2018.11.127","article-title":"An update on Drug Repurposing: Re-written saga of the drug\u2019s fate","volume":"110","author":"GNS","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3389\/fonc.2017.00273","article-title":"Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics","volume":"7","author":"Hernandez","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jcpt.12507","article-title":"Off-label drug use in oncology: A systematic review of literature","volume":"42","author":"Saiyed","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Herrero Fernandez, M., Molina Villaverde, R., Arroyo Yustos, M., Navarro Exp\u00f3sito, F., Lopez Gonzalez, J.L., Luque Infantes, M.R., and Alvarez-Mon Soto, M. (2019). The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.01210"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41580-020-0258-4","article-title":"COVID-19: Organoids go viral","volume":"21","author":"Clevers","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.4184","article-title":"Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen","volume":"22","author":"Xu","year":"2016","journal-title":"Nat. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13046-019-1257-1","article-title":"Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures","volume":"38","author":"Barra","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Engel, R.M., Chan, W.H., Nickless, D., Hlavca, S., Richards, E., Kerr, G., Oliva, K., McMurrick, P.J., Jard\u00e9, T., and Abud, H.E. (2020). Patient-Derived Colorectal Cancer Organoids Upregulate Revival Stem Cell Marker Genes following Chemotherapeutic Treatment. J. Clin. Med., 9.","DOI":"10.3390\/jcm9010128"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccell.2019.12.013","article-title":"Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers","volume":"37","author":"Sudhan","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI97924","article-title":"DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine","volume":"128","author":"Yu","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1038\/s41467-019-11867-6","article-title":"Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening","volume":"10","author":"Kim","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","article-title":"A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids","volume":"2","author":"Phan","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"955","DOI":"10.15252\/msb.20177697","article-title":"Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations","volume":"13","author":"Jabs","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"ref_133","unstructured":"NIH (2020, November 05). National Institutes of Health Office of Cancer Genomics (OCG) NIH, Available online: https:\/\/ocg.cancer.gov\/programs\/hcmi\/overview."},{"key":"ref_134","unstructured":"OcellO, B.V. (2020, November 29). Available online: https:\/\/ocello.nl\/."},{"key":"ref_135","unstructured":"(2020, November 29). Crown Bioscience Inc. Available online: https:\/\/www.crownbio.com\/."},{"key":"ref_136","unstructured":"(2020, November 29). Cellesce Ltd. Available online: https:\/\/cellesce.com\/."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3636\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:26Z","timestamp":1760179286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":136,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["cancers12123636"],"URL":"https:\/\/doi.org\/10.3390\/cancers12123636","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}